Matthew M. Seavey
- Immunology top 10%
- Oncology top 10%
- Molecular Biology
- Biotechnology top 2%
- Rheumatology top 10%
- Co-authors
- Paweł DobrzańskiYvonne PatersonPaulo MaciagZhen-Kun PanLily LuTim R. MosmannLaurence M. WoodBruce Ruggeri
- Topics
- Cancer Research and Treatments (7 papers)Immunotherapy and Immune Responses (7 papers)Cytokine Signaling Pathways and Interactions (5 papers)
- Cited by
- BiotechnologyImmunologyOncology
- Partner nations
- United States
In The Last Decade
Matthew M. Seavey
21 papers receiving 787 citations
Peers
Comparison fields: 5 of 81
- Immunology 359
- Oncology 255
- Molecular Biology 219
- Biotechnology 207
- Rheumatology 139
Countries citing papers authored by Matthew M. Seavey
This map shows the geographic impact of Matthew M. Seavey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Seavey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Seavey more than expected).
Fields of papers citing papers by Matthew M. Seavey
This network shows the impact of papers produced by Matthew M. Seavey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Seavey. The network helps show where Matthew M. Seavey may publish in the future.
Co-authorship network of co-authors of Matthew M. Seavey
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Seavey. A scholar is included among the top collaborators of Matthew M. Seavey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Seavey. Matthew M. Seavey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | 33 | |
| 4 | 53 | |
| 5 | 65 | |
| 6 | 103 | |
| 7 | 43 | |
| 8 | 60 | |
| 9 | 14 | |
| 10 | 1 | |
| 11 | 63 | |
| 12 | 10 | |
| 13 | 48 | |
| 14 | 60 | |
| 15 | 20 | |
| 16 | 74 | |
| 17 | 46 | |
| 18 | 23 | |
| 19 | 18 | |
| 20 | 8 |
About Matthew M. Seavey
Matthew M. Seavey is a scholar working on Biotechnology, Immunology and Rheumatology, having authored 21 papers that have together received 818 indexed citations. Recurring topics across this work include Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (7 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Biotechnology (207 citations), Immunology (359 citations) and Oncology (255 citations). Matthew M. Seavey has collaborated with scholars based in United States. Frequent co-authors include Paweł Dobrzański, Yvonne Paterson, Paulo Maciag, Zhen-Kun Pan, Lily Lu, Tim R. Mosmann, Laurence M. Wood, Bruce Ruggeri, Patrick Guirnalda and Sandra Rivera. Their work appears in journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.